FeesSafety
Pluang+

NSCLC market set to double by 2036 as biomarker-driven treatments advance at ESMO 2026.

Market News
19 Nov 2026, 01:00 WIB
Delveinsight
View Source
Bullish
NSCLC market set to double by 2036 as biomarker-driven treatments advance at ESMO 2026.

The non-small cell lung cancer (NSCLC) market across seven major countries is projected to grow from USD 33 billion in 2025 to about USD 67 billion by 2036, driven by advances in biomarker-guided therapies highlighted at the ESMO 2026 Congress. Key Phase III trial results showed improved survival with MET, KRAS, and TROP2 targeted treatments, signaling a shift from chemotherapy to precision medicine. Despite progress, challenges remain with late diagnosis, resistance to therapies, and high treatment costs. The evolving treatment landscape and expanding pipeline suggest significant growth opportunities in NSCLC care over the next decade.

The NSCLC treatment landscape and its projected market growth provide context for Pluang's health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 18, 2026 23:03 WIB: out of 150 priced US health-sector stocks, 69 rose and 80 fell. Notable movers include ImmunityBio Inc. (IBRX) at USD 6.59 with a +5.35% change and a typical hold time of 4 days, Erasca Inc. (ERAS) at USD 13.22 down -4.82% with 45% sell and 55% buy order activity, and Elevance Health Inc. (ELV) at USD 413.77 down -4.65% with 99% sell orders and a typical hold time of 11 days.

More News

Investing in the S&P 500 since 2000 grew $1,000 to $8,050 despite a 13-year flat period.

Investing in the S&P 500 since 2000 grew $1,000 to $8,050 despite a 13-year flat period.

Investing in the S&P 500 at the tech bubble peak in 2000 led to over a decade of flat returns, but staying invested paid off. Since March 24, 2000, the S&P 500 has returned 705% with dividends reinvested, turning $1,000 into $8,050, averaging just ov...

Market News
Bullish
14 minutes ago
GTA VI breaks records with $1.65B sales and near-perfect reviews at launch.

GTA VI breaks records with $1.65B sales and near-perfect reviews at launch.

Grand Theft Auto VI has launched with a record-breaking start, selling 17.07 million units worth $1.65 billion in its first 24 hours, more than doubling the debut sales of GTA V. The game has received overwhelmingly positive reviews, including a near...

Market News
Bullish
25 minutes ago
Amazon forecasts Q4 operating income up 14-34%, driven by strong ad growth and sales efficiency.

Amazon forecasts Q4 operating income up 14-34%, driven by strong ad growth and sales efficiency.

Amazon expects its Q4 operating income to rise to $28.5-$33.5 billion, a 14-34% increase from last year, on sales growth of 12-16%. This profit growth outpaces sales growth, signaling improved efficiency. Advertising revenue, the most profitable part...

Company Fundamentals
Bullish
29 minutes ago
Cerebras and IonQ race in AI and quantum computing with strong growth but high risks for 2027.

Cerebras and IonQ race in AI and quantum computing with strong growth but high risks for 2027.

Cerebras Systems and IonQ represent two cutting-edge tech fields: AI hardware and quantum computing. Cerebras focuses on large wafer-scale processors for AI workloads, showing strong revenue growth and a solid cash reserve but faces manufacturing and...

Market News
Neutral
29 minutes ago
Tech stocks TSMC, ASML, and GE Vernova offer better AI investment value than volatile Anthropic IPO.

Tech stocks TSMC, ASML, and GE Vernova offer better AI investment value than volatile Anthropic IPO.

The Nasdaq is down 11% from its high amid expectations of a Federal Reserve rate hike in December. Anthropic is launching its IPO in this volatile market, but established tech suppliers like Taiwan Semiconductor Manufacturing (TSMC), ASML, and GE Ver...

Bullish
43 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App